Cargando…

Clinical Meaning of Stromal Tumor Infiltrating Lymphocytes (sTIL) in Early Luminal B Breast Cancer

SIMPLE SUMMARY: Stromal tumor infiltrating lymphocytes (sTIL) are a validated predictive and prognostic biomarker in non-luminal breast cancer. Our aim was to evaluate their clinical relevance in luminal (hormone receptor positive, HER2 negative) early breast cancer. Our results show that, although...

Descripción completa

Detalles Bibliográficos
Autores principales: García-Torralba, Esmeralda, Pérez Ramos, Miguel, Ivars Rubio, Alejandra, Navarro-Manzano, Esther, Blaya Boluda, Noel, de la Morena Barrio, Pilar, García-Garre, Elisa, Martínez Díaz, Francisco, Chaves-Benito, Asunción, García-Martínez, Elena, Ayala de la Peña, Francisco
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10216816/
https://www.ncbi.nlm.nih.gov/pubmed/37345183
http://dx.doi.org/10.3390/cancers15102846
_version_ 1785048388391141376
author García-Torralba, Esmeralda
Pérez Ramos, Miguel
Ivars Rubio, Alejandra
Navarro-Manzano, Esther
Blaya Boluda, Noel
de la Morena Barrio, Pilar
García-Garre, Elisa
Martínez Díaz, Francisco
Chaves-Benito, Asunción
García-Martínez, Elena
Ayala de la Peña, Francisco
author_facet García-Torralba, Esmeralda
Pérez Ramos, Miguel
Ivars Rubio, Alejandra
Navarro-Manzano, Esther
Blaya Boluda, Noel
de la Morena Barrio, Pilar
García-Garre, Elisa
Martínez Díaz, Francisco
Chaves-Benito, Asunción
García-Martínez, Elena
Ayala de la Peña, Francisco
author_sort García-Torralba, Esmeralda
collection PubMed
description SIMPLE SUMMARY: Stromal tumor infiltrating lymphocytes (sTIL) are a validated predictive and prognostic biomarker in non-luminal breast cancer. Our aim was to evaluate their clinical relevance in luminal (hormone receptor positive, HER2 negative) early breast cancer. Our results show that, although sTIL are associated with a better response to neoadjuvant chemotherapy, they are also associated with worse biological features (proliferation, higher stage) and poorer prognosis in luminal B breast cancer. TIL might improve prognostic stratification and contribute to therapeutic decision-making in the early high-risk setting of luminal B breast cancer. ABSTRACT: Luminal breast cancer (BC) is associated with less immune activation, and the significance of stromal lymphocytic infiltration (sTIL) is more uncertain than in other BC subtypes. The aim of this study was to investigate the predictive and prognostic value of sTIL in early luminal BC. The study was performed with an observational design in a prospective cohort of 345 patients with predominantly high-risk luminal (hormone receptor positive, HER2 negative) BC and with luminal B features (n = 286), in which the presence of sTIL was analyzed with validated methods. Median sTIL infiltration was 5% (Q1–Q3 range (IQR), 0–10). We found that sTIL were associated with characteristics of higher biological and clinical aggressiveness (tumor and lymph node proliferation and stage, among others) and that the percentage of sTIL was predictive of pathologic complete response in patients treated with neoadjuvant chemotherapy (OR: 1.05, 95%CI 1.02–1.09, p < 0.001). The inclusion of sTIL (any level of lymphocytic infiltration: sTIL > 0%) in Cox regression multivariable prognostic models was associated with a shorter relapse-free interval (HR: 4.85, 95%CI 1.33–17.65, p = 0.016) and significantly improved its performance. The prognostic impact of sTIL was independent of other clinical and pathological variables and was mainly driven by its relevance in luminal B BC.
format Online
Article
Text
id pubmed-10216816
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-102168162023-05-27 Clinical Meaning of Stromal Tumor Infiltrating Lymphocytes (sTIL) in Early Luminal B Breast Cancer García-Torralba, Esmeralda Pérez Ramos, Miguel Ivars Rubio, Alejandra Navarro-Manzano, Esther Blaya Boluda, Noel de la Morena Barrio, Pilar García-Garre, Elisa Martínez Díaz, Francisco Chaves-Benito, Asunción García-Martínez, Elena Ayala de la Peña, Francisco Cancers (Basel) Article SIMPLE SUMMARY: Stromal tumor infiltrating lymphocytes (sTIL) are a validated predictive and prognostic biomarker in non-luminal breast cancer. Our aim was to evaluate their clinical relevance in luminal (hormone receptor positive, HER2 negative) early breast cancer. Our results show that, although sTIL are associated with a better response to neoadjuvant chemotherapy, they are also associated with worse biological features (proliferation, higher stage) and poorer prognosis in luminal B breast cancer. TIL might improve prognostic stratification and contribute to therapeutic decision-making in the early high-risk setting of luminal B breast cancer. ABSTRACT: Luminal breast cancer (BC) is associated with less immune activation, and the significance of stromal lymphocytic infiltration (sTIL) is more uncertain than in other BC subtypes. The aim of this study was to investigate the predictive and prognostic value of sTIL in early luminal BC. The study was performed with an observational design in a prospective cohort of 345 patients with predominantly high-risk luminal (hormone receptor positive, HER2 negative) BC and with luminal B features (n = 286), in which the presence of sTIL was analyzed with validated methods. Median sTIL infiltration was 5% (Q1–Q3 range (IQR), 0–10). We found that sTIL were associated with characteristics of higher biological and clinical aggressiveness (tumor and lymph node proliferation and stage, among others) and that the percentage of sTIL was predictive of pathologic complete response in patients treated with neoadjuvant chemotherapy (OR: 1.05, 95%CI 1.02–1.09, p < 0.001). The inclusion of sTIL (any level of lymphocytic infiltration: sTIL > 0%) in Cox regression multivariable prognostic models was associated with a shorter relapse-free interval (HR: 4.85, 95%CI 1.33–17.65, p = 0.016) and significantly improved its performance. The prognostic impact of sTIL was independent of other clinical and pathological variables and was mainly driven by its relevance in luminal B BC. MDPI 2023-05-20 /pmc/articles/PMC10216816/ /pubmed/37345183 http://dx.doi.org/10.3390/cancers15102846 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
García-Torralba, Esmeralda
Pérez Ramos, Miguel
Ivars Rubio, Alejandra
Navarro-Manzano, Esther
Blaya Boluda, Noel
de la Morena Barrio, Pilar
García-Garre, Elisa
Martínez Díaz, Francisco
Chaves-Benito, Asunción
García-Martínez, Elena
Ayala de la Peña, Francisco
Clinical Meaning of Stromal Tumor Infiltrating Lymphocytes (sTIL) in Early Luminal B Breast Cancer
title Clinical Meaning of Stromal Tumor Infiltrating Lymphocytes (sTIL) in Early Luminal B Breast Cancer
title_full Clinical Meaning of Stromal Tumor Infiltrating Lymphocytes (sTIL) in Early Luminal B Breast Cancer
title_fullStr Clinical Meaning of Stromal Tumor Infiltrating Lymphocytes (sTIL) in Early Luminal B Breast Cancer
title_full_unstemmed Clinical Meaning of Stromal Tumor Infiltrating Lymphocytes (sTIL) in Early Luminal B Breast Cancer
title_short Clinical Meaning of Stromal Tumor Infiltrating Lymphocytes (sTIL) in Early Luminal B Breast Cancer
title_sort clinical meaning of stromal tumor infiltrating lymphocytes (stil) in early luminal b breast cancer
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10216816/
https://www.ncbi.nlm.nih.gov/pubmed/37345183
http://dx.doi.org/10.3390/cancers15102846
work_keys_str_mv AT garciatorralbaesmeralda clinicalmeaningofstromaltumorinfiltratinglymphocytesstilinearlyluminalbbreastcancer
AT perezramosmiguel clinicalmeaningofstromaltumorinfiltratinglymphocytesstilinearlyluminalbbreastcancer
AT ivarsrubioalejandra clinicalmeaningofstromaltumorinfiltratinglymphocytesstilinearlyluminalbbreastcancer
AT navarromanzanoesther clinicalmeaningofstromaltumorinfiltratinglymphocytesstilinearlyluminalbbreastcancer
AT blayaboludanoel clinicalmeaningofstromaltumorinfiltratinglymphocytesstilinearlyluminalbbreastcancer
AT delamorenabarriopilar clinicalmeaningofstromaltumorinfiltratinglymphocytesstilinearlyluminalbbreastcancer
AT garciagarreelisa clinicalmeaningofstromaltumorinfiltratinglymphocytesstilinearlyluminalbbreastcancer
AT martinezdiazfrancisco clinicalmeaningofstromaltumorinfiltratinglymphocytesstilinearlyluminalbbreastcancer
AT chavesbenitoasuncion clinicalmeaningofstromaltumorinfiltratinglymphocytesstilinearlyluminalbbreastcancer
AT garciamartinezelena clinicalmeaningofstromaltumorinfiltratinglymphocytesstilinearlyluminalbbreastcancer
AT ayaladelapenafrancisco clinicalmeaningofstromaltumorinfiltratinglymphocytesstilinearlyluminalbbreastcancer